Research News and Research

RSS

Scientific symposium to examine new approaches to schizophrenia drug development

Despite significant investment in research and development by pharmaceutical companies, the last decade has seen a marked decline in the number of drugs developed and approved for schizophrenia. A multi-day symposium at the New York Academy of Sciences on Wednesday, March 9 - Friday, March 11 will convene world-leading experts in clinical, translational, and basic neuroscience to address this problem by examining novel, state-of-the-art approaches to schizophrenia drug development.

5 Mar 2011

Summer Street Research announces recent closing of financing for IMUC

Summer Street Research Partners is pleased to announce the recent closing of a financing for ImmunoCellular Therapeutics, Ltd., a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers.

5 Mar 2011

NCI renews Ariadne's license for Pathway Studio Enterprise system

Ariadne, a leader in bioinformatics software and knowledge integration, announced that National Cancer Institute has renewed their license for Pathway Studio Enterprise system that includes the ResNet Mammalian database and Ariadne MedScan text processing technology for site-wide use.

5 Mar 2011

Judge stays ruling against health law, sets deadline for White House to appeal

A federal judge in Florida issued a stay regarding his own January ruling in which he overturned the health law. However, this breathing room is only temporary — he also put the health law on the fast track to the Supreme Court.

5 Mar 2011

Family left on sideline in health care crisis

Decision-making on behalf of patients in persistent vegetative states is always a delicate matter, especially if, like Ms. Nyirahabiyambere, they have not left a directive.

5 Mar 2011

Medical oncology included in Directive for the sake of better cancer care in Europe: ESMO

The European Society for Medical Oncology, the leading professional organization for medical oncology in Europe, proudly announced that medical oncology has been included among the medical specialties covered by Directive 2005/36/EC on the recognition of professional qualifications, as announced yesterday by the Commission.

5 Mar 2011

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.

5 Mar 2011

New HQ of David H. Koch Institute for Integrative Cancer Research officially dedicated

The new seven-story headquarters of the David H. Koch Institute for Integrative Cancer Research at MIT, where scientists and engineers are working together to pursue new ways to treat, detect and prevent cancer, will be officially dedicated today at 4 p.m.

5 Mar 2011

Researchers use qMRI to confirm effect of CS treatment in patients with OA

A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.

5 Mar 2011

House votes to repeal health law's tax reporting requirement

Lawmakers continue to be at odds over how to pay for the repeal of this provision, which was originally included in the overhaul as a means to raise revenue to pay for it. The House's offset, for instance, would recoup advance tax subsidies given to lower- and middle-income people to buy insurance if their incomes exceed a certain threshold during the same calendar year.

5 Mar 2011

Caris Life Sciences to highlight new approaches for gynecologic cancers at SGO 2011 conference

Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, today announced highlights from the company's upcoming symposium, "Using Biomarker Expression to Guide Therapy: An Evidence-Based Approach for Gynecologic Cancers," at the Society of Gynecologic Oncologists 2011 Annual Meeting on Women's Cancer in Orlando, FL on March 6.

5 Mar 2011

BNCT treatment proves effective in treating recurrent head, neck cancer

Biologically targeted BNCT treatment is based on producing radiation inside a tumour using boron-10 and thermal neutrons. Boron-10 is introduced into cancer cells with the help of a special carrier substance (phenylalanine), after which the tumour is irradiated with lowenergy neutrons.

5 Mar 2011

LUC, Trinity sign LOI to strengthen Catholic health care

Loyola University Chicago and Trinity Health have signed a Letter of Intent that could lead to the consolidation of Trinity Health and the Loyola University Health System, a wholly owned subsidiary of the University.

5 Mar 2011

Aflac receives two Communitas Awards for excellence in community service, corporate social responsibility

Aflac, the company that pays cash benefits fast when you are sick or hurt, today announced that it has been awarded two Communitas Awards for excellence in community service and corporate social responsibility. Winners are recognized for specific programs involving volunteerism, philanthropy, or ethical and sustainable business practices.

5 Mar 2011

First implantable heart transplant using new LVAD performed at University of Utah Hospital

Surgeons at University of Utah Hospital have performed the hospital's first implant of a new-generation left ventricular assist device using the HeartWare HVAD. The tiny, partial artificial heart device is being used as part of a national research study for patients with advanced heart failure who are not candidates for heart transplantation.

5 Mar 2011

Major providers of prison medical care set to merge

Valitas Health Services plans to acquire America Service Group for $250 million, merging two of the largest providers of correctional health care. Valitas, of St. Louis, is the parent company of Correctional Medical Services.

5 Mar 2011

Acos: FTC member says health law 'centerpiece' needs clarification

Thomas Rosch, a Republican member of the U.S. Federal Trade Commission, urged the Obama administration to clarify a centerpiece of the new health care law that raises antitrust issues.

5 Mar 2011

Bessel beam plane illumination microscopy reveals 3-D structures of living cells

A new microscope invented by scientists at Howard Hughes Medical Institute's Janelia Farm Research Campus will let researchers use an exquisitely thin sheet of light -- similar to that used in supermarket bar-code scanners -- to peer inside single living cells, revealing the three-dimensional shapes of cellular landmarks in unprecedented detail.

5 Mar 2011

EIF's NCCRA, SU2C to encourage people get screened for colorectal cancer

Golden Globe and Academy Award-nominated actor and musician Terrence Howard appears in a moving window display at Rockefeller Plaza this month, encouraging viewers to get screened for colorectal cancer as an ambassador for the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and Stand Up To Cancer.

5 Mar 2011

Monthly liver enzyme tests not required for PAH patients taking Letairis tablets: FDA

The U.S. Food and Drug Administration today announced that monthly liver enzyme tests are no longer required for those taking Letairis tablets (ambrisentan), used to treat high blood pressure in the vessels that carry blood to the lungs (pulmonary arterial hypertension, or PAH).

5 Mar 2011

Research News and Research

Scientific symposium to examine new approaches to schizophrenia drug development

Summer Street Research announces recent closing of financing for IMUC

NCI renews Ariadne's license for Pathway Studio Enterprise system

Judge stays ruling against health law, sets deadline for White House to appeal

Family left on sideline in health care crisis

Medical oncology included in Directive for the sake of better cancer care in Europe: ESMO

Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics

New HQ of David H. Koch Institute for Integrative Cancer Research officially dedicated

Researchers use qMRI to confirm effect of CS treatment in patients with OA

House votes to repeal health law's tax reporting requirement

Caris Life Sciences to highlight new approaches for gynecologic cancers at SGO 2011 conference

BNCT treatment proves effective in treating recurrent head, neck cancer

LUC, Trinity sign LOI to strengthen Catholic health care

Aflac receives two Communitas Awards for excellence in community service, corporate social responsibility

First implantable heart transplant using new LVAD performed at University of Utah Hospital

Major providers of prison medical care set to merge

Acos: FTC member says health law 'centerpiece' needs clarification

Bessel beam plane illumination microscopy reveals 3-D structures of living cells

EIF's NCCRA, SU2C to encourage people get screened for colorectal cancer

Monthly liver enzyme tests not required for PAH patients taking Letairis tablets: FDA

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News